6.
McKim D, Niraula A, Tarr A, Wohleb E, Sheridan J, Godbout J
. Neuroinflammatory Dynamics Underlie Memory Impairments after Repeated Social Defeat. J Neurosci. 2016; 36(9):2590-604.
PMC: 4879207.
DOI: 10.1523/JNEUROSCI.2394-15.2016.
View
7.
Schatz J, Brown R, Pascual J, Hsu L, DeBaun M
. Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease. Neurology. 2001; 56(8):1109-11.
DOI: 10.1212/wnl.56.8.1109.
View
8.
Kato G, Piel F, Reid C, Gaston M, Ohene-Frempong K, Krishnamurti L
. Sickle cell disease. Nat Rev Dis Primers. 2018; 4:18010.
DOI: 10.1038/nrdp.2018.10.
View
9.
Vay S, Blaschke S, Klein R, Fink G, Schroeter M, Rueger M
. Minocycline mitigates the gliogenic effects of proinflammatory cytokines on neural stem cells. J Neurosci Res. 2015; 94(2):149-60.
DOI: 10.1002/jnr.23686.
View
10.
Lettre G
. Blocking HbS Polymerization in SCD. Cell. 2020; 180(5):819.
DOI: 10.1016/j.cell.2020.01.019.
View
11.
Kohman R, Bhattacharya T, Kilby C, Bucko P, Rhodes J
. Effects of minocycline on spatial learning, hippocampal neurogenesis and microglia in aged and adult mice. Behav Brain Res. 2013; 242:17-24.
PMC: 3725815.
DOI: 10.1016/j.bbr.2012.12.032.
View
12.
Portela G, Butters M, Brooks M, Candra L, Rosano C, Novelli E
. Comprehensive assessment of cognitive function in adults with moderate and severe sickle cell disease. Am J Hematol. 2022; 97(9):E344-E346.
PMC: 9378513.
DOI: 10.1002/ajh.26643.
View
13.
Brodowicz J, Przegalinski E, Muller C, Filip M
. Ceramide and Its Related Neurochemical Networks as Targets for Some Brain Disorder Therapies. Neurotox Res. 2017; 33(2):474-484.
PMC: 5766709.
DOI: 10.1007/s12640-017-9798-6.
View
14.
Vichinsky E, Neumayr L, Gold J, Weiner M, Rule R, Truran D
. Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA. 2010; 303(18):1823-31.
PMC: 2892214.
DOI: 10.1001/jama.2010.562.
View
15.
Jorgensen D, Metti A, Butters M, Mettenburg J, Rosano C, Novelli E
. Disease severity and slower psychomotor speed in adults with sickle cell disease. Blood Adv. 2018; 1(21):1790-1795.
PMC: 5728099.
DOI: 10.1182/bloodadvances.2017008219.
View
16.
DeBaun M, Jordan L, King A, Schatz J, Vichinsky E, Fox C
. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv. 2020; 4(8):1554-1588.
PMC: 7189278.
DOI: 10.1182/bloodadvances.2019001142.
View
17.
Thompson Jr R, Gustafson K, Bonner M, Ware R
. Neurocognitive development of young children with sickle cell disease through three years of age. J Pediatr Psychol. 2002; 27(3):235-44.
DOI: 10.1093/jpepsy/27.3.235.
View
18.
Wohleb E, Powell N, Godbout J, Sheridan J
. Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior. J Neurosci. 2013; 33(34):13820-33.
PMC: 3755721.
DOI: 10.1523/JNEUROSCI.1671-13.2013.
View
19.
Asle-Rousta M, Oryan S, Ahmadiani A, Rahnema M
. Activation of sphingosine 1-phosphate receptor-1 by SEW2871 improves cognitive function in Alzheimer's disease model rats. EXCLI J. 2015; 12:449-61.
PMC: 4566907.
View
20.
Hardy R, Rached N, Jones J, Archer D, Hyacinth H
. Role of age and neuroinflammation in the mechanism of cognitive deficits in sickle cell disease. Exp Biol Med (Maywood). 2020; 246(1):106-120.
PMC: 7797997.
DOI: 10.1177/1535370220958011.
View